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1. Introduction 
G protein-coupled receptors (GPCRs) are members of a large gene family encoded by 
approximately 1000 members (Lefkowitz, 2007; Pierce et al., 2002). They are also known as 
seven transmembrane domain (7TM) receptors as they are characterized by a single 
polypeptide that has seven membrane spanning helical domains. Members of this family 
include receptors that bind to biogenic amines, chemokines, opioids, lipids, among many 
more. They mediate a wide variety of physiological processes ranging from 
neurotransmission, cardiovascular function, leukocyte chemotaxis and analgesia. GPCRs are 
important clinically as many have been implicated in many diseases and are targets for 
approximately 50% of all marketed medicines (Drews, 2000). 
Upon binding to their cognate ligands GPCRs mediate down stream signaling via 
heterotrimeric GTP-binding proteins (G protein). G proteins are comprised of an -subunit 
(G) and a tightly associated dimer of  and -subunits (G). In the inactive state G is bound 
to GDP and exists in an inactive conformation. Once the GPCR is activated by its cognate 
ligand, conformational changes in the receptor induce the exchange of GDP for GTP on G 
leading to its activation and dissociation from the  subunits. The activated G (G-GTP) and 
dissociated  subunits activate downstream effector molecules contributing to GPCR 
signaling. One effector molecule is adenylyl cyclase and upon its activation it leads to the 
production of cyclic AMP (cAMP), which in turn activates the protein kinase A (PKA), a 
serine/threonine kinase that phosphorylates many different substrates. Another effector 
molecule that is activated is phospholipase C, which catalyzes the hydrolysis of phosphatidyl 
4,5 bisphosphate to produce inositol 1,4,5-trisphosphate and diacyclglycerol, which in turn 
leads to calcium release from intracellular stores and activation of protein kinase C, 
respectively. Recently, it has become apparent that GPCRs may also signal independent of the 
G protein, and this typically involves proteins known as -arrestins (DeWire et al., 2007). 
To ensure that signals are of the appropriate magnitude and duration GPCR signaling is 
tightly regulated. This is critical because perturbations in the regulatory processes that control 
GPCR signaling may contribute to the cause of human pathologies (Hernandez et al., 2003). 
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Regulation of signaling is complex and involves multiple steps. It involves inactivation of the 
G protein and degradation of second messengers (Nelson et al., 2007; Perry et al., 2002). 
Regulation also involves a series of complex events that occur at the level of the receptor. 
Regulation may occur by second-messenger-dependent protein kinases PKA and PKC, which 
may also phosphorylate GPCRs, in addition to other downstream factors, when they become 
activated. Additional regulation occurs by another family of serine/threonine kinases known 
as G protein-coupled receptor kinases (GRKs), which phosphorylate activated receptors 
resulting in the binding of another class of proteins known as arrestins (Fig 1) (Krupnick and 
Benovic, 1998). Here we will focus on recent advances that have linked non-visual arrestins to 
a novel function by regulating the endosomal sorting machinery with a role in trafficking of 
GPCRs into the degradative pathway.  
2. Traditional roles of -arrestins 
Mammalian arrestins comprise a family of four members that can be sub-divided into two 
groups: visual (arrestin-1 and arrestin-4) and non-visual arrestins (-arrestin-1 and -
arrestin-2, also known as arrestin-2 and arrestin-3, respectively) (Gurevich and Gurevich, 
2006a). Visual arrestins are restricted in distribution to the visual system. Arrestin-1 is found 
in high abundance in rod cells whereas arrestin-4 is found in cone cells. Non-visual arrestins 
are ubiquitously expressed and likely regulate the signaling of many GPCRs.  
The classical known function of arrestins, in conjunction with GRKs, is to mediate GPCR 
desensitization, a phenomenon in which responsiveness to chronic stimulation is attenuated 
(Fig. 1). Arrestins were initially identified in the visual system as a 48-kDa protein capable of 
blocking light induced signaling of rhodopsin (Wilden et al., 1986). Subsequently, -arrestins 
were identified and found to function in non-visual systems in an analogous manner to visual 
arrestins in that they blocked agonist-induced signaling of the 2-adrenergic receptor (2AR) 
(Lohse et al., 1990). Arrestins are typically recruited to GPCRs that are activated by their 
cognate ligands and phosphorylated by GRKs (Krupnick and Benovic, 1998). Arrestin binding 
uncouples the G protein from the receptor via steric hindrance culminating in attenuated 
signaling (Lohse et al., 1990). Arrestins may also contribute to signal termination by promoting 
degradation of second messengers (Perry et al., 2002) (Nelson et al., 2007) and also by 
promoting GPCR internalization through clathrin-coated pits based on their ability to bind to 
components of the internalization machinery (Goodman et al., 1996; Laporte et al., 1999).  
 
Fig. 1. Schematic depicting -arrestin mediated desensitization and internalization of GPCRs.  
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1) Under basal conditions, the heterotrimeric GTP binding protein (G protein), which is 
comprised of an -subunit (G) and a tightly associated dimer of  and -subunits (G), is 
bound to GDP and is in an inactive conformation. 2) Upon binding to its cognate ligand 
(yellow oval), conformational changes in the GPCR induce the exchange of GDP for GTP on 
the -subunit (G) leading to its activation and dissociation from the  subunits. The 
activated -subunit (G-GTP) and  subunits activate downstream effector molecules 
contributing to GPCR signaling. 3) Signaling is rapidly terminated in part by GPCR kinase 
(GRK) recruitment to the activated receptor, which phosphorylates the receptor on serine 
and/or threonine residues that are located within the carboxy-terminal tail and/or on the 
intracellular loops. 4) Arrestins are rapidly recruited to the phosphorylated receptor, which 
upon binding uncouple the receptor from the associated G subunit via steric hindrance, 
contributing to signal termination and to the phenomenon known as desensitization. 5) 
Arrestins subsequently interact with clathrin and AP2, two important components of the 
internalization machinery. 6) This results in the recruitment of activated and 
phosphorylated receptors for internalization via clathrin coated pits.  
The crystal structure of -arrestins revealed that they consist of two distinct elongated 
domains (N and C domains) and a carboxy-terminal tail (C-tail) (Han et al., 2001; Hirsch et 
al., 1999; Milano et al., 2002). The N and C domains are independent folding units composed 
of anti-parallel beta sheets connected by a short linker or hinge sequence. Under basal 
conditions or in an inactive state, the N and C domains are compact and the C-tail is 
anchored to the N domain. Upon binding to phosphorylated GPCRs arrestins undergo 
significant conformational changes in which a rearrangement of the N and C domains 
occurs and the C-tail is released (Gurevich and Gurevich, 2006b). The C-tail of -arrestins 
contains the binding sites for clathrin and AP2, two important components of the 
internalization machinery (Goodman et al., 1996; Laporte et al., 1999). The exposure of the 
C-tail enables clathrin and AP2 binding and subsequent recruitment of receptors to clathrin-
coated pits for internalization. The arrestin C-tail also contains sites for post-translational 
modifications that also regulate the ability of arrestins to promote GPCR internalization. 
Nitrosylation of -arrestin-2 on the terminal cysteine residue 409 increases its ability to 
interact with clathrin and facilitate 2AR internalization (Ozawa et al., 2008). SUMOylation 
of -arrestin-2 on lysine residue 400 has also been shown to have a role in 2AR 
internalization, likely by facilitating interactions with AP2 (Wyatt et al., 2011). Detailed 
molecular insight regarding how these events are coordinated to properly execute -
arrestins roles in GPCR internalization remains to be determined.  
3. Role of -arrestins in GPCR recycling 
Once removed from the plasma membrane by internalization receptors are delivered to 
early endosomes (Hanyaloglu and von Zastrow, 2008; Marchese et al., 2008). Once on 
endosomes, receptors may enter into the recycling pathway and return to the plasma 
membrane giving rise to functional resensitization of GPCR responsiveness. Upon agonist 
activation the 2AR is rapidly phosphorylated and internalized onto endosomes before it is 
rapidly recycled to the plasma membrane (Krueger et al., 1997; Pippig et al., 1995; von 
Zastrow and Kobilka, 1992). Internalization onto endosomes may be a prerequisite for 
receptor resensitization of signaling. The acidic environment of the endosomal compartment 
may induce a conformational change in the receptor enabling an endosomal associated 
www.intechopen.com
 
Chemical Biology 
 
256 
phosphatase to dephosphorylate the receptor (Krueger et al., 1997). Dephosphorylation of 
the receptor may facilitate its entry into the recycling pathway for delivery to the plasma 
membrane and functional resensitization.  
 
Fig. 2. Trafficking pathways for GPCRs.  
Upon activation by its cognate ligand (oval), GPCRs are typically sequestered into 
specialized microdomains of the plasma membrane that are responsible for endocytosis. 
These areas of the plasma membrane pinch off, forming vesicles that eventually fuse with 
early endosomes, where the receptors are delivered. Some receptors may be modified with 
ubiquitin moieties at the plasma membrane, although the ubiquitin moiety is not required to 
promote receptor internalization. Once on early endosomes, GPCRs are sorted for either 
entering the recycling or degradative pathways. GPCRs that enter the degradative pathway 
are typically modified with ubiquitin, which serves as a signal for sorting into 
multivesicular bodies (MVBs). MVBs fuse with lysosomes where degradation of the receptor 
occurs. GPCRs that are not ubiquitinated may enter the recycling pathway and are returned 
to the plasma membrane via recycling endosomes, giving rise to functional resensitization of 
signaling. The ubiquitin moieties on some receptors may be removed by the action of 
deubiquitinating enzymes (DUBs), which may occur on endosomes, and redirect receptors 
targeted for the degradative pathway into the recycling pathway. 
-arrestins may also mediate receptor recycling at a post-internalization step by playing a 
direct role on endosomes. For many GPCRs, the interaction with -arrestins is transient. 
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Once -arrestins bind and desensitization and receptor internalization have initiated, the 
two proteins disassociate while the receptor internalizes onto endosomes (Oakley et al., 
1999; Oakley et al., 2001; Oakley et al., 2000). Once on endosomes the receptor rapidly 
recycles to the plasma membrane. However, for a subset of GPCRs, not only does -arrestin 
binding promote desensitization and internalization, -arrestins may co-internalize and co-
localize with the receptor on endosomes. The ability of -arrestin to co-internalize with 
GPCRs is dependent upon their ability to form a stable complex with the GPCR. This slows 
down the recycling of the receptor, likely by preventing the receptor from efficiently 
entering into the recycling pathway. Receptors that form a stable interaction with -arrestins 
tend to have multiple serine/threonine residue clusters near the end of their carboxy-
terminal tail (Oakley et al., 1999; Oakley et al., 2001). Phosphorylation of these clusters 
promotes high affinity -arrestin binding thereby allowing it to remain bound to the 
receptor while internalization onto endosomes occurs. The stability of the interaction and 
the trafficking pattern of -arrestins also correlates with their ubiquitination status (Shenoy 
and Lefkowitz, 2003; Shenoy et al., 2009). Upon receptor activation, -arrestins may also be 
subject to ubiquitination (Shenoy et al., 2001). -arrestin-2 interacts with the E3 ubiquitin 
ligase Mdm2 and the deubiquitinating enzyme USP33 (Shenoy et al., 2001; Shenoy et al., 
2009). Upon activation of GPCRs for which the interaction with -arrestin-2 is transient, 
such as 2AR, ubiquitination of -arrestin-2 is rapid, but it is rapidly deubiquitinated by 
USP33. In contrast, upon activation of GPCRs for which the interaction with -arrestin-2 is 
stable, such as the vasopressin V2 receptor, ubiquitination is also rapid, but it is not 
deubiquitinated by USP33, resulting in sustained ubiquitination. One possible explanation 
to account for this difference between receptors is that -arrestin-2 may undergo differential 
conformational changes when bound to distinct receptors which may affect its ability to 
interact with USP33 (Shenoy et al., 2009). Therefore discrete conformational changes 
regulated by different GPCRs may control -arrestin deubiquitination and thus their ability 
to co-traffic with receptors onto endosomes. 
-arrestins may also play a role in GPCR recycling independent of their role in promoting 
GPCR internalization. Although, -arrestins are not required for internalization of the N-
formyl peptide receptor (FPR), they are required for promoting FPR recycling. Agonist-
induced internalization of FPR occurs in a -arrestin-independent fashion, as FPR 
internalization is not altered in mouse embryonic fibroblasts (MEFs) isolated from -
arrestin-1 and -arrestin-2 knockout out mice (Vines et al., 2003). However, recycling of the 
receptor is impaired in the -arrestin knock-out MEFs and restored in cells in which -
arrestin-1 and -arrestin-2 are re-expressed. Although not required for internalization, 
agonist activation promotes -arrestin binding to FPR and its co-internalization with the 
receptor onto endosomes. Once on endosomes -arrestins promote recycling through a 
mechanism that remains to be determined.  
4. -arrestins as adaptors for E3 ubiquitin ligases 
In addition to entering the recycling pathway, GPCRs may be sorted into the degradative 
pathway (Fig. 2) for delivery to lysosomes where they are degraded (Hanyaloglu and von 
Zastrow, 2008; Marchese et al., 2008). The functional consequence of this is long-term 
attenuation of signaling giving rise to a phenomenon known as downregulation. -
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arrestin may serve as an adaptor to recruit E3 ubiquitin ligases directly to activated 
receptors to mediate their ubiquitination. The ubiquitin moiety serves as a sorting signal 
on endosomes for targeting the receptor into the degradative pathway. Receptor 
ubiquitination occurs at the plasma membrane even though the attached ubiquitin serves 
as a sorting signal on endosomes. Receptor mutants lacking ubiquitination sites 
internalize normally but are defective in their ability to be sorted or targeted to lysosomes 
(Marchese and Benovic, 2001; Shenoy et al., 2001). A role for -arrestins as an E3 ubiquitin 
ligase adaptor for receptor ubiquitination was first suggested in studies examining the 
regulation of 2AR (Shenoy et al., 2001). Agonist-promoted ubiquitination of 2AR is 
impaired in MEFs isolated from -arrestin-2 knock-out mice, suggesting that -arrestin-2 
mediates ubiquitination of 2AR. In contrast, -arrestin-1 is not involved in 2AR 
ubiquitination. -arrestin-2 interacts with the HECT-domain E3 ubiquitin ligase Nedd4, 
which mediates ubiquitination of 2AR (Shenoy et al., 2008). Although -arrestin-2 
interacts with Mdm2, it does not mediate ubiquitination of 2AR (Shenoy et al., 2001). 
Depletion of Nedd4 by siRNA attenuates 2AR ubiquitination and lysosomal targeting 
and the interaction between 2AR and Nedd4 is dependent upon the presence of -
arrestin-2 (Shenoy et al., 2008). This is consistent for a role of -arrestin-2 serving as an 
adaptor to recruit Nedd4 to 2AR.  
Alternatively, Nedd4 may be recruited to 2AR independent of -arrestin-2 involving the 
arrestin domain-containing protein ARRDC3 (Nabhan et al., 2010). ARRDs are a family of 
6 mammalian proteins related to yeast proteins called arrestin-related trafficking (ART) 
adaptor proteins that were first characterized in Saccharomyces cerevisiae (Lin et al., 2008). 
Collectively these proteins have been referred to as alpha-arrestins to distinguish them 
from -arrestins (Alvarez, 2008). Although sharing very little amino acid sequence 
identity with mammalian -arrestins, bioinformatics modeling revealed that alpha-
arrestins have an arrestin-fold consisting of N and C domains. This overall architecture 
may represent a conserved structural design found in seemingly distantly related 
proteins. The retromer component Vps26, although it does not share primary sequence 
identity with mammalian arrestins, has structurally similar folded N and C domains (Shi 
et al., 2006). One key distinguishing feature of ARRDs compared to -arrestins or visual 
arrestins is that ARRDs have a long carboxy-terminal region harboring PY motifs (Lin et 
al., 2008). PY motifs are short stretches of amino acids typically found in the context of 
PPxY and PPPY, where P is a proline residue, x is any amino acid and Y is a tyrosine 
residue (Einbond and Sudol, 1996). PY motifs are typically recognized by WW domains, 
which are domains of approximately 30 amino acids containing two highly conserved 
tryptophan residues (Macias et al., 2002). The Nedd4-like family of HECT-domain E3 
ubiquitin ligases, comprised of 9 members in the human genome, is characterized by the 
presence of 4 tandemly linked WW domains (Ingham et al., 2004). Substrates that have PY 
motifs interact directly with their cognate E3s via the WW domains, however, many 
substrates do not have PY motifs and are believed to interact indirectly with these E3s 
through an adaptor protein that harbors a PY motif (Shearwin-Whyatt et al., 2006). 
Recently, it was reported that ARRDC3 interacts with 2AR and serves as an adaptor for 
Nedd4-dependent ubiquitination of the receptor (Nabhan et al., 2010). Depletion of 
ARRDC3 attenuates agonist-induced ubiquitination and lysosomal targeting of 2AR 
(Nabhan et al., 2010). ARRDC3 is predicted to bind directly to Nedd4 via its PY motif and 
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to 2AR. Mammalian arrestins do not contain PY motifs and it is unclear how Nedd4 
interacts with -arrestin-2. It remains to be determined how the actions of -arrestin-2 and 
ARRDC3 are coordinated to mediate Nedd4-dependent 2AR ubiquitination. 
Interestingly, -arrestin-1 interacts with another member of the Nedd4-like family of E3 
ubiquitin ligases known as AIP4 (Bhandari et al., 2007). AIP4 mediates ubiquitination and 
endosomal sorting of the GPCR chemokine receptor C-X-C receptor 4 (CXCR4) (Marchese 
et al., 2003). As with all members of this family, AIP4 has a C2 domain, 4 tandemly-linked 
WW domains and the catalytic HECT domain. Unlike Nedd4, however, AIP4 has a 
proline-rich region that may bind to a subset of SH3 domains (Angers et al., 2004). The 
interaction between -arrestin-1 and AIP4 is direct and it is mediated by AIP4 WW 
domains I and II, not III and IV (Bhandari et al., 2007). In addition to interacting with PY 
motifs, WW domains are also known to interact with phosphorylated serine or threonine 
residues in the presence of an adjacent proline residue (p(S/T)P) (Lu et al., 1999; Verdecia 
et al., 2000). Presently, it remains to be determined how the AIP4 WW-domains interact 
with -arrestin-1. Interestingly, a non-canonical WW-mediated interaction involving AIP4 
has been recently reported (Bhandari et al., 2009). The WW domains of AIP4 have been 
shown to interact with phosphorylated serine residues in the absence of nearby proline 
residues. Phosphorylation of serine residues within the C-tail of CXCR4 mediates a direct 
interaction with AIP4 via WW domains I and II (Bhandari et al., 2009). A receptor mutant 
in which C-tail serine residues 324 and 325 were changed to alanine residues (S324/5A) 
attenuated binding to AIP4 (Bhandari et al., 2009; Marchese and Benovic, 2001). 
Accordingly, the S324/5A CXCR4 receptor mutant shows defective ubiquitination and 
degradation (Bhandari et al., 2009). Agonist-promoted phosphorylation of these residues 
occurs at the plasma membrane leading to AIP4 recruitment to the plasma membrane 
where the receptor is ubiquitinated. Therefore for CXCR4 ubiquitination, an adaptor is 
not required because the Nedd4-like E3 AIP4 can interact directly with the receptor. 
Similar to the mechanism of the interaction between AIP4 and CXCR4, the WW domains 
of Nedd4 may also interact with its substrates via phosphorylated serine residues in the 
absence of nearby proline residues (Edwin et al., 2010). Therefore, phosphorylated serine 
residues in the absence of proline residues may represent a general recognition motif for 
WW domains. To our knowledge, Nedd4 and AIP4 are the only Nedd4-like E3 ubiquitin 
ligases assigned to the ubiquitination of mammalian GPCRs, but it is tempting to 
speculate that CXCR4 recognition by AIP4 may represent a general mechanism by which 
Nedd4-like E3 family members interact with and ubiquitinate GPCRs.  
5. -arrestins as adaptors for endosomal sorting  
Although -arrestin-1 interacts with AIP4 it is not involved in ubiquitination of CXCR4. 
Depletion of -arrestin-1 by siRNA does not block CXCR4 ubiquitination and nor does it 
block CXCR4 internalization (Bhandari et al., 2007). However, -arrestin-1 depletion blocks 
CXCR4 degradation by preventing its trafficking from early to late endosomes, suggesting a 
role for -arrestin-1 at a sorting step on endosomes (Bhandari et al., 2007). AIP4 also 
mediates sorting of CXCR4 on endosomes, in addition to its role at the plasma membrane in 
mediating CXCR4 ubiquitination (Marchese et al., 2003). Both -arrestin-1 and AIP4 co-
localize with CXCR4 on early endosomes where they likely function to sort CXCR4 into the 
degradative pathway. Therefore -arrestin-1 acts on early endosomes as an endosomal 
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adaptor molecule to regulate the trafficking of ubiquitinated CXCR4 from early endosomes 
to lysosomes (Bhandari et al., 2007; Malik and Marchese, 2010).  
One function of endosomal -arrestin-1 is likely to recruit ubiquitinated CXCR4 to the 
endosomal sorting required for transport (ESCRT) pathway, the degradative pathway that 
targets ubiquitinated receptors for lysosomal degradation [Fig. 3 and (Malik and 
Marchese, 2010)]. The ESCRT machinery consists of four discrete multi-protein complexes 
named ESCRT 0-III (Henne et al., 2011). The ESCRT complexes act in a sequential and a 
coordinated manner to target ubiquitinated cargo into intraluminal vesicles (ILVs) of 
multivesicular bodies, which then fuse with lysosomes where degradation occurs. 
Delivery into the ESCRT pathway is thought to occur when the ubiquitin moiety on 
ubiquitinated receptors is initially recognized by the ubiquitin binding domains (UBD) 
found in ESCRT 0 (Raiborg and Stenmark, 2009; Shields et al., 2009). ESCRT-0 
subsequently recruits ESCRT-I to the endosomal membrane, followed by recruitment of 
ESCRT II and III, culminating in sorting of the receptor into ILVs [reviewed in (Raiborg 
and Stenmark, 2009)]. ESCRT-0 is comprised of two proteins: HRS (hepatocyte growth 
factor–regulated tyrosine kinase substrate) and STAM (signal transduction adaptor 
molecule). -arrestin-1 interacts with ESCRT-0 through a direct interaction with STAM-1 
(Malik and Marchese, 2010). Therefore it is possible that -arrestin-1 facilitates 
ubiquitinated CXCR4 recruitment to ESCRT-0 for entry into the ESCRT pathway.  
 
 
 
Fig. 3. Proposed model for the roles of -arrestins in endosomal sorting of CXCR4.  
1) -arrestin-1 (Arr1) interacts with ESCRT-0 through a direct interaction with STAM-1. 
STAM-1 together with HRS form the core components of ESCRT-0. Although the 
ubiquitin moiety on CXCR4 may be recognized by the ubiquitin interacting motif (UIM) 
present in HRS, one role of -arrestin-1 may be to facilitate the interaction of 
ubiquitinated CXCR4 with ESCRT-0. 2) A second role for -arrestin-1 in conjunction with 
STAM-1 may serve to recruit the E3 ubiquitin ligase AIP4 for ubiquitination of HRS. 3) 
The ubiquitin moiety on HRS may induce an auto-inhibitory conformation through an 
interaction with its UIM domain to relieve HRS of its sorting function. 4) The precise 
molecular details remain unknown, but this somehow leads to the delivery of 
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ubiquitinated CXCR4 to downstream elements of the ESCRT machinery for subsequent 
entry into ILVs and delivery to lysosomes for degradation.  
Surprisingly, depletion of STAM-1 by siRNA accelerates CXCR4 degradation, indicating 
that STAM-1 negatively regulates CXCR4 entry into the degradative pathway (Malik and 
Marchese, 2010). This function of STAM-1 is dependent on the interaction with -arrestin-
1 as disruption of this interaction by expressing fragments encoding the minimal binding 
regions of each respective protein also accelerates CXCR4 degradation. Although detailed 
mechanistic insight is lacking, the function of the STAM-1/-arrestin-1 interaction may be 
to regulate the ubiquitination status of HRS. Disruption of the STAM-1/-arrestin-1 
interaction decreases CXCR4-induced ubiquitination HRS, indicating that STAM-1/-
arrestin-1 function to mediate HRS ubiquitination. As -arrestin-1 interacts with AIP4, it 
may be that together with STAM-1 they function as adaptors for recruiting AIP4 to 
endosomes to mediate ubiquitination of HRS. This suggests that ubiquitination of HRS 
serves to delay endosomal sorting of CXCR4. One possible explanation is that the 
ubiquitin moiety on HRS may interact with its own UIM, a type of ubiquitin binding 
domain, resulting in an auto-inhibitory conformation that inhibits the ability of HRS to 
perform its sorting function (Hoeller et al., 2006). Alternatively, the ubiquitin moiety on 
HRS may be required to interact with other ubiquitin binding domains present in other 
proteins of the ESCRT machinery and possibly other factors. Regardless, this may 
represent a way in which receptors can regulate their own sorting efficiency (Malik and 
Marchese, 2010).  
Remarkably, linking GPCRs to the ESCRT machinery may be an evolutionary conserved 
function of -arrestins (Herrador et al., 2010; Herranz et al., 2005). Rim8, an arrestin-like 
molecule in Saccharomyces cerevisiae related to PalF, an arrestin-like molecule in the fungus 
Aspergillus nidulans, interacts with components of the ESCRT machinery (Herrador et al., 
2010). Sequence homology predicts that Rim8 and PalF share a limited amount of 
sequence identity with mammalian arrestins. In fungi, PalF may interact with a putative 
seven transmembrane domain (7TM) receptor in an analogous manner to which -
arrestins interact with ligand activated GPCRs (Herranz et al., 2005). Rim8 and PalF are 
involved in a signaling cascade that senses the pH of the environment. In fungi, pH is 
recognized in part by the putative 7TM receptor called PalH. Akaline pH is thought to 
activate PalH and to promote its binding to PalF. The predicted cytoplasmic tail of PalH 
interacts with PalF and this interaction may be necessary to activate the intracellular 
signaling pathway necessary for pH sensing. Intriguingly, genetic screens have revealed 
that components of the ESCRT machinery, including ESCRT-I, ESCRT-II and ESCRT-III 
subunits Snf7 and Vps20, but not ESCRT-0 and ESCRT-III subunits Vps2 and Vps24, are 
also necessary for pH sensing (Xu et al., 2004). Rim8, the orthologue of PalF binds to 
Rim21, a 7TM receptor with pH sensing capabilities (Herrador et al., 2010). Not only does 
the arrestin-like molecule Rim8 interact with the receptor Rim21 it also interacts with the 
ESCRT machinery. Rim8 interacts with ESCRT-I subunits Vps23 and Vps28 and as genetic 
evidence suggests that ESCRT-0 is not involved in pH sensing signaling (Xu et al., 2004), 
therefore the arrestin-like protein Rim8 may link the 7TM receptor Rim21 directly to 
ESCRT-I. This raises the intriguing possibility that arrestin recruitment of GPCRs to the 
ESCRT machinery may represent a conserved function. 
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6. Conclusion 
In addition to their roles in GPCR desensitization, internalization and recycling, -arrestins 
may also function in GPCR endosomal sorting. In this capacity they may serve to link 
ubiquitinated GPCRs to the ESCRT machinery for subsequent targeting to lysosomes. This 
may represent an evolutionary conserved function of -arrestins, suggesting they may play 
a broad role in GPCR endosomal sorting. Further studies are required to gain greater 
mechanistic insight into the process by which -arrestins integrate with the ESCRT 
machinery to target GPCRs for lysosomal degradation. 
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